<DOC>
<DOCID>XIN.19971218.0040</DOCID>
<HEADER>
<DATE>1997-12-18</DATE>
</HEADER>
<BODY>
<HEADLINE>
<S ID=717>
( (IP-HLN (IP-SBJ (NP-PN-SBJ (NR 中国)) 
                  (VP (VV 利用) 
                      (NP-OBJ (NN 草药)) 
                      (IP (NP-SBJ (-NONE- *PRO*)) 
			  (VP (VV 治疗) 
			      (NP-OBJ (NN 糖尿病)))))) 
          (VP (VV 获) 
              (NP-OBJ (ADJP (JJ 重大)) 
                      (NP (NN 进展))))) ) 
</S>
</HEADLINE>
<TEXT>
<P>
<S ID=718>
( (FRAG  (NR 新华社) 
         (NR 北京) 
         (NT 十二月) 
         (NT 十八日) 
         (NN 电) )) 
</S>
<S ID=719>
( (IP (NP-SBJ (NP-PN (NR 中国) 
                     (NN 中医) 
                     (NN 研究院)) 
              (NP (NN 研究) 
                  (NN 人员))) 
      (VP (NP-TMP (NT 今天)) 
          (VP (VV 说) 
	      (PU ，) 
	      (IP-OBJ (NP-SBJ (PN 他们)) 
		      (VP (ADVP (AD 已)) 
			  (DVP (VP (VA 成功)) 
			       (DEV 地)) 
			  (PP-DIR (P 从) 
				  (LCP (NP (NN 草药)) 
				       (LC 中))) 
			  (VP (VRD (VV 提取) 
				   (VV 出)) 
			      (NP-OBJ (NP-APP (CP (WHNP-1 (-NONE- *OP*)) 
						  (CP (IP (NP-SBJ (-NONE- *T*-1)) 
							  (VP (PP-DIR (P 对) 
								      (NP (NN 糖尿病))) 
							      (VP (VE 有) 
								  (NP-OBJ (ADJP (JJ 特殊)) 
									  (NP (NN 疗效)))))) 
						      (DEC 的))) 
					      (ADJP (JJ 新)) 
					      (NP (NN 药))) 
				      (NP-PN (PU “) 
					     (NN 糖脉康) 
					     (PU ”)))))))) 
      (PU 。)) ) 
</S>
<S ID=720>
( (IP (NP-SBJ (ADJP (JJ 有关)) 
              (NP (NN 专家))) 
      (VP (VV 认为) 
          (PU ，) 
          (IP-OBJ (NP-SBJ (DNP (NP (DP (DT 这) 
				       (QP (CD 一))) 
				   (ADJP (JJ 新)) 
				   (NP (NN 药))) 
			       (DEG 的)) 
                          (NP (NN 研制) 
			      (NN 成功) 
                              (CC 和) 
                              (NN 推广))) 
                  (VP (ADVP (AD 将)) 
                      (VP (VV 有助于) 
			  (IP-OBJ (NP-SBJ (-NONE- *PRO*))
				  (VP (VV 抑制) 
				      (NP-OBJ (NP (NN 糖尿病) 
						  (NN II型)) 
					      (DNP (PP (P 在) 
						       (NP (NP-PN-APP (NR 中国) 
								      (PU 、) 
								      (NR 印度) 
								      (CC 和) 
								      (NR 非洲) 
								      (ETC 等)) 
							   (ADJP (JJ 发展中)) 
							   (NP (NN 国家)))) 
						   (DEG 的)) 
					      (NP (NN 流行))))))))) 
      (PU 。)) ) 
</S>
</P>
<P>
<S ID=721>
( (IP (LCP-LOC (NP (CP (WHNP-1 (-NONE- *OP*)) 
		       (CP (IP (NP-SBJ (-NONE- *T*-1)) 
			       (VP (PP-LOC (P 在) 
					   (NP-PN (NR 中国) 
						  (NN 中医) 
						  (NN 研究院))) 
				   (VP (VV 召开)))) 
			   (DEC 的))) 
		   (CP (WHNP-2 (-NONE- *OP*)) 
		       (CP (IP (NP-SBJ (-NONE- *T*-2)) 
			       (VP (PP-LGS (P 由) 
					   (NP (DNP (NP (NP-PN-APP (NP-PN (NR 中国) 
									  (NN 科学院)) 
								   (PU 、) 
								   (NP-PN (NR 中国) 
									  (NN 医学) 
									  (NN 科学院)) 
								   (ETC 等)) 
							(NP (NN 单位))) 
						    (DEG 的)) 
					       (NP (NN 院士) 
						   (PU 、) 
						   (NN 医学) 
						   (NN 专家) 
						   (CC 和) 
						   (NN 生物学家)))) 
				   (VP (VV 参加)))) 
			   (DEC 的))) 
		   (NP-TTL-PN (PU “) 
			      (NN 糖尿病) 
			      (NN 防治) 
			      (NN 对策) 
			      (NN 讨论会) 
			      (PU ”))) 
	       (LC 上)) 
      (PU ，) 
      (NP-SBJ (NN 记者)) 
      (VP (VRD (VV 了解) 
	       (VV 到)) 
	  (PU ，) 
	  (IP-OBJ (IP (NP-TMP (NT 目前)) 
		      (NP-SBJ (DP (DT 全)) 
			      (NP (NN 世界))) 
		      (VP (VE 有) 
			  (NP-OBJ (NN 糖尿病) 
				  (NN 患者)) 
			  (NP-EXT (QP (CD 一点三亿多)) 
				  (NP (NN 人))))) 
		  (PU ，) 
		  (IP (NP-ADV (NN 其中)) 
		      (LCP-SBJ (QP (CD 百分之九十)) 
			       (LC 以上)) 
		      (VP (VC 为) 
			  (NP-PRD (NN 糖尿病) 
				  (NN II型)))))) 
      (PU 。)) ) 
</S>
<S ID=722>
( (IP (NP-TPC (NN 糖尿病) 
	      (NN II型)) 
      (NP-SBJ (NP-APP (NP (PN 其)) 
		      (NP (NN 并发症))) 
	      (NP (ADVP (AD 如)) 
		  (NP (NN 冠心病) 
		      (PU 、) 
		      (NN 脑血管病) 
		      (PU 、) 
		      (NN 肾病) 
		      (PU 、) 
		      (NN 失明) 
		      (CC 和) 
		      (NN 下肢) 
		      (NN 坏死) 
		      (ETC 等)))) 
      (VP (ADVP (AD 已)) 
	  (VP (VV 成为) 
	      (NP-OBJ (CP (WHNP-3 (-NONE- *OP*)) 
			  (CP (IP (NP-SBJ (-NONE- *T*-3)) 
				  (VP (ADVP (AD 仅)) 
				      (VP (VV 次于) 
					  (NP-OBJ (NN 癌症) 
						  (CC 和) 
						  (NN 艾滋病))))) 
			      (DEC 的))) 
		      (NP (NN 人类)) 
		      (QP (OD 第三)) 
		      (ADJP (JJ 大)) 
		      (NP (NN 杀手))))) 
      (PU 。)) ) 
</S>
</P>
<P>
<S ID=723>
( (IP (NP-PN-SBJ (NR 中国)) 
      (VP (VP (NP-TMP (NT 目前)) 
	      (VP (VE 有) 
		  (NP-OBJ (QP (CD 两千多万)) 
			  (NP (NN 糖尿病) 
			      (NN 患者))))) 
	  (PU ，) 
	  (VP (ADVP (AD 仅)) 
	      (VP (VV 次于) 
		  (NP-PN-OBJ (NR 美国)))) 
	  (PU ，) 
	  (VP (VV 居) 
	      (QP-OBJ (NP (NN 世界)) 
		      (QP (OD 第二))))) 
      (PU 。)) ) 
</S>
<S ID=724>
( (IP (NP-SBJ (NN 专家)) 
      (VP (VV 预测) 
	  (PU ，) 
	  (IP-OBJ (PP (P 随着) 
		      (NP (NP (NN 经济) 
			      (NN 发展)) 
			  (PU 、) 
			  (NP (DNP (NP (NN 生活) 
				       (NN 水平)) 
				   (DEG 的)) 
			      (NP (NN 提高))) 
			  (CC 和) 
			  (NP (DNP (NP (NN 饮食) 
				       (NN 习惯)) 
				   (DEG 的)) 
			      (NP (NN 改善))))) 
		  (PU ，) 
		  (PP-TMP (P 到) 
			  (NP (QP (OD 二十一))
			      (NP (NN 世纪)))) 
		  (PU ，) 
		  (NP-SBJ (NN 糖尿病) 
			  (NN II型)) 
		  (VP (ADVP (AD 将)) 
		      (PP-LOC (P 在) 
			      (NP (NP-PN-APP (NR 中国) 
					     (PU 、) 
					     (NR 印度) 
					     (CC 和) 
					     (NR 非洲) 
					     (ETC 等)) 
				  (ADJP (JJ 发展中)) 
				  (NP (NN 国家)))) 
		      (VP (VV 流行))))) 
      (PU 。)) ) 
</S>
<S ID=725>
( (IP (IP (LCP-TMP (NP (NT 近年)) 
		   (LC 来)) 
	  (PU ，) 
	  (NP-SBJ (NP-PN (NR 美国)) 
		  (DP (DT 每) 
		      (CLP (M 年))) 
		  (NP (NN 糖尿病) 
		      (NN 医疗费))) 
	  (VP (QP-PRD (ADVP (AD 约)) 
		      (QP (CD 一百亿) 
			  (CLP (M 美元)))))) 
      (PU ，) 
      (IP (NP-SBJ (NP-PN (NR 印度)) 
		  (NP (NT 去年) 
		      (NN 糖尿病) 
		      (NN 医疗费))) 
	  (VP (VC 为) 
	      (QP-PRD (CD 六点一亿) 
		      (CLP (M 美元))))) 
      (PU ，) 
      (IP (NP-PN-SBJ (NR 中国)) 
	  (VP (ADVP (AD 尚)) 
	      (VP (VE 无) 
		  (NP-OBJ (ADJP (JJ 具体)) 
			  (NP (NN 统计)))))) 
      (PU ，) 
      (IP (ADVP (AD 但)) 
	  (NP-SBJ (NP-PN (NR 中国)) 
		  (NP (NN 糖尿病) 
		      (NN 人数))) 
	  (VP (ADVP (AD 正)) 
	      (PP-MNR (P 以) 
		      (NP (DNP (NP (DP (DT 每) 
				       (CLP (M 年))) 
				   (QP (CD 七十五万)) 
				   (ADJP (JJ 新)) 
				   (NP (NN 患者))) 
			       (DEG 的)) 
			  (NP (NN 速度)))) 
	      (VP (VV 递增)))) 
      (PU 。)) ) 
</S>
</P>
<P>
<S ID=726>
( (IP (NP-SBJ (NN 研究) 
	      (NN 人员)) 
      (VP (VP (VV 介绍))
	  (VP (VV 说)
	      (PU ，)
	      (IP-OBJ (NP-SBJ (CP (WHNP-1 (-NONE- *OP*)) 
				  (CP (IP (NP-SBJ (-NONE- *pro*)) 
					  (VP (NP-LOC (NN 国外)) 
					      (NP-TMP (NT 目前)) 
					      (ADVP (AD 普遍)) 
					      (VP (VV 使用) 
						  (NP-OBJ (-NONE- *T*-1))))) 
				      (DEC 的))) 
			      (DP (DT 各) 
				  (CLP (M 种))) 
			      (ADJP (NP (NN 化学)) 
				    (ADJP (JJ 合成))) 
			      (ADJP (JJ 降糖)) 
			      (NP (NN 药))) 
		      (VP (PP-DIR (P 对) 
				  (NP (NN 糖尿病) 
				      (NN 并发症))) 
			  (ADVP (AD 均)) 
			  (VP (VE 无) 
			      (NP-OBJ (CP (WHNP-2 (-NONE- *OP*)) 
					  (IP (NP-SBJ (-NONE- *T*-2)) 
					      (VP (ADVP (AD 多)) 
						  (VP (VA 大))))) 
				      (NP (NN 防治) 
					  (NN 作用)))))))) 
      (PU 。)) ) 
</S>
<S ID=727>
( (IP (IP (NP-SBJ (NP-PN (PU “) 
			 (NN 糖脉康) 
			 (PU ”)) 
		  (NP (NN 颗粒))) 
	  (VP (VP (CC 不仅) 
		  (VP (VV 降低) 
		      (NP-OBJ (NN 血糖))) 
		  (PU ，) 
		  (CC 而且) 
		  (VP (ADVP (AD 还)) 
		      (VP (VV 能) 
			  (VP (ADVP (AD 显著)) 
			      (VP (VV 降低) 
				  (NP-OBJ (NN 胆固醇) 
					  (CC 和) 
					  (NN 甘油三脂)))))))
	      (PU ，)
	      (VP (PP-DIR (P 对) 
			  (NP (NN 糖尿病) 
			      (NN 并发症))) 
		  (VP (VE 有) 
		      (NP-OBJ (ADJP (JJ 特殊)) 
			      (NP (NN 疗效))))))) 
      (PU ，) 
      (IP (NP-SBJ (NN 卫生部)) 
	  (VP (VP (ADVP (AD 已)) 
		  (VP (VV 颁发) 
		      (NP-OBJ (NN 文件)))) 
	      (VP (BA 将) 
		  (IP-OBJ (NP-SBJ (PN 其)) 
			  (VP (VV 定为) 
			      (NP-OBJ (ADJP (JJ 国家级)) 
				      (NP (ADJP (JJ 新)) 
					  (NP (NN 药))) 
				      (NP (NN 保密) 
					  (NN 品种)))))))) 
      (PU 。)) ) 
</S>
</P>
<P>
<S ID=728>
( (IP (NP-SBJ (NP-APP (NP (NP-APP (NP (NP-PN (NR 中科院)) 
				      (NP (NN 院士)) 
				      (PU 、)) 
				  (NP (NP-PN (NN 世界) 
					     (NN 卫生) 
					     (NN 组织)) 
				      (NP (NN 传统) 
					  (NN 医学) 
					  (NN 顾问)))) 
			  (NP-PN (NR 陈可冀))) 
		      (ETC 等)) 
	      (ADJP (JJ 与会)) 
	      (NP (NN 专家) 
		  (NN 教授))) 
      (VP (VP (VV 认为) 
	      (IP-OBJ (NP-SBJ (DNP (NP-PN (PU “) 
					  (NN 糖脉康) 
					  (PU ”)) 
				   (DEG 的)) 
			      (NP (NN 问世))) 
		      (VP (VC 是) 
			  (NP-PRD (CLP (M 件)) 
				  (ADJP (JJ 好)) 
				  (NP (NN 事)))))) 
	  (PU ，) 
	  (VP (ADVP (AD 同时)) 
	      (VP (VV 希望) 
		  (IP-OBJ (NP-SBJ (NN 研究) 
				  (NN 人员)) 
			  (VP (VP (PP-DIR (P 对) 
					  (NP (NN 胰岛素) 
					      (CC 和) 
					      (NN 血流变))) 
				  (VP (VV 做) 
				      (NP-OBJ (ADJP (JJ 进一步)) 
					      (NP (NN 观察))))) 
			      (PU ，) 
			      (VP (PP-DIR (P 对) 
					  (NP (DNP (NP-PN (PU “) 
							  (NN 糖脉康) 
							  (PU ”)) 
						   (DEG 的)) 
					      (NP (NP (ADJP (JJ 有效)) 
						      (NP (NN 成分))) 
						  (CC 和) 
						  (NP (NN 机理))))) 
				  (VP (VV 做) 
				      (NP-OBJ (NP (NN 深入)) 
					      (NP (NN 研究))))) 
			      (PU ，) 
			      (VP (VV 使) 
				  (NP-OBJ (PN 其)) 
				  (IP (NP-SBJ (-NONE- *PRO*)) 
				      (VP (PP-LOC (P 在) 
						  (LCP (NP (NN 国际)) 
						       (LC 上))) 
					  (PU ，) 
					  (PP-LOC (ADVP (AD 包括)) 
						  (PP (P 在) 
						      (LCP (NP (DNP (PP (P 与) 
									(NP (ADJP (JJ 发达)) 
									    (NP (NN 国家)))) 
								    (DEG 的)) 
							       (NP (NN 竞争))) 
							   (LC 中)))) 
					  (VP (VV 立于) 
					      (NP-OBJ (NN 不败之地))))))))))) 
      (PU 。)) ) 
</S>
</P>
<P>
<S ID=729>
( (IP (PP-PRP (P 为) 
	      (IP (NP-SBJ (-NONE- *PRO*)) 
		  (VP (VV 增强) 
		      (IP-OBJ (NP-SBJ (NP-PN-APP (PU “) 
						 (NN 糖脉康) 
						 (PU ”)) 
				      (DP (DT 这) 
					  (CLP (M 类))) 
				      (CP (WHNP-1 (-NONE- *OP*)) 
					  (CP (IP (NP-SBJ (-NONE- *T*-1)) 
						  (VP (VV 面向) 
						      (NP-OBJ (QP (OD 二十一))
							      (NP (NN 世纪))))) 
					      (DEC 的))) 
				      (NP (NN 中药)) 
				      (ADJP (JJ 新)) 
				      (NP (NN 药))) 
			      (VP (PP-LOC (P 在) 
					  (LCP (NP (NN 国际) 
						   (NN 市场)) 
					       (LC 上))) 
				  (VP (VE 有) 
				      (NP-OBJ (NN 竞争力)))))))) 
      (PU ，) 
      (NP-SBJ (NP-PN (NR 中国) 
		     (NN 中医) 
		     (NN 研究院)) 
	      (NP-PN (NR 中汇) 
		     (NN 制药) 
		     (NN 公司))) 
      (VP (VP (VV 投资) 
	      (QP-OBJ (CD 两亿) 
		      (CLP (M 元)))) 
	  (VP-PRP (PP-LOC (P 在) 
			  (NP-PN (NR 四川) 
				 (NR 成都))) 
		  (VP (VV 建成) 
		      (AS 了) 
		      (NP-OBJ (CP (WHNP-2 (-NONE- *OP*)) 
				  (CP (IP (NP-TPC (-NONE- *T*-2)) 
					  (NP-SBJ (ADJP (JJ 年)) 
						  (NP (NN 生产) 
						      (NN 能力))) 
					  (VP (VC 为) 
					      (QP-PRD (CD 五十亿) 
						      (CLP (M 元))))) 
				      (DEC 的))) 
			      (NP (NN 生产) 
				  (NN 基地)))))) 
      (PU 。)) ) 
</S>
<S ID=730>
( (IP (NP-SBJ (-NONE- *pro*)) 
      (VP (VV 预计) 
	  (IP-OBJ (IP (NP-TMP (NT 明年)) 
		      (NP-SBJ (DNP (NP-PN (PU “) 
					  (NN 糖脉康) 
					  (PU ”)) 
				   (DEG 的)) 
			      (NP (NN 产值))) 
		      (VP (ADVP (AD 将)) 
			  (VP (VV 达到) 
			      (QP-OBJ (CD 六亿) 
				      (CLP (M 元)))))) 
		  (PU ，) 
		  (IP (NP-SBJ (-NONE- *pro*)) 
		      (VP (NP-TMP (NT 二０００年)) 
			  (ADVP (AD 将)) 
			  (VP (VV 达到) 
			      (QP-OBJ (CD 十五亿) 
				      (CLP (M 元)))))))) 
      (PU 。)) ) 
</S>
</P>
<P>
<S ID=731>
( (IP (PP (P 据) 
	  (NP (NN 了解))) 
      (PU ，) 
      (IP (IP (NP-LOC (DP (DT 全)) 
		      (NP (NN 世界))) 
	      (DP-ADV (DT 每) 
		      (CLP (M 年))) 
	      (NP-SBJ (DNP (NP (NN 草药)) 
			   (DEG 的)) 
		      (NP (NN 销售额))) 
	      (VP (QP-PRD (ADVP (AD 约)) 
			  (QP (CD 一百五十亿) 
			      (CLP (M 美元)))))) 
	  (PU ，) 
	  (IP (NP-SBJ (NP-PN (NR 中国)) 
		      (NP (NN 中药) 
			  (NN 出口))) 
	      (VP (ADVP (AD 只)) 
		  (VP (VE 有) 
		      (QP-OBJ (CD 六亿) 
			      (CLP (M 美元)))))) 
	  (PU ，) 
	  (CC 而且) 
	  (IP (LCP-SBJ (QP (CD 百分之七十)) 
		       (LC 以上)) 
	      (VP (VC 是) 
		  (NP-PRD (CP (WHNP-1 (-NONE- *OP*)) 
			      (CP (IP (NP-SBJ (-NONE- *T*-1)) 
				      (VP (ADVP (AD 未)) 
					  (VP (VV 加) 
					      (NP-OBJ (NN 附加值))))) 
				  (DEC 的))) 
			  (NP (NN 药材)))))) 
      (PU 。)) ) 
</S>
<S ID=732>
( (IP (NP-SBJ (NN 医药界) 
	      (NN 专家)) 
      (VP (VV 预测) 
	  (PU ，) 
	  (IP-OBJ (NP-SBJ (NP (DNP (NP-PN (PU “) 
					  (NN 糖脉康) 
					  (PU ”)) 
				   (DEG 的)) 
			      (NP (NN 推广))) 
			  (CC 和) 
			  (NP (DNP (NP (NN 生产) 
				       (NN 基地)) 
				   (DEG 的)) 
			      (NP (NN 建成)))) 
		  (VP (ADVP (AD 将)) 
		      (VP (VV 有利于) 
			  (IP-OBJ (NP-SBJ (-NONE- *pro*))
				  (VP (VV 改变) 
				      (NP-OBJ (CP-APP (IP (NP-SBJ (ADJP (JJ 国产)) 
								  (NP (NN 中药))) 
							  (VP (PP-LOC (P 在) 
								      (NP (NN 国际) 
									  (NN 中药) 
									  (NN 市场))) 
							      (VP (VA 不景气)))) 
						      (DEC 的)) 
					      (NP (NN 局面))))))))) 
	  (PU 。)) ) 
</S>
<S ID=733>
( (FRAG (PU （) 
	(VV 完) 
	(PU ）) )  ) 
</S>
</P>
</TEXT>
</BODY>
</DOC>
